These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7041329

  • 1. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
    Chiba M, Ohneda A, Sakai T, Goto Y.
    Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
    [Abstract] [Full Text] [Related]

  • 2. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A, Matsuda K, Chiba M, Iimura Y, Yamagata S.
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [Abstract] [Full Text] [Related]

  • 3. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T, Ohneda A, Nihei J, Kobayashi T.
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [Abstract] [Full Text] [Related]

  • 4. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA, Beard JC, Halter JB, Judzewitsch R, Best JD, Porte D.
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [Abstract] [Full Text] [Related]

  • 5. Insulin response to glucose or glucagon in subclinical diabetes previously injected with tolbutamide.
    Ohneda A, Watanabe K, Maruhama Y, Itabashi H, Horigome K.
    Tohoku J Exp Med; 1977 Jan; 121(1):27-32. PubMed ID: 835136
    [Abstract] [Full Text] [Related]

  • 6. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A.
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug 20; 51(8):676-84. PubMed ID: 1237421
    [Abstract] [Full Text] [Related]

  • 7. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA, Morse EL, Amin PM.
    J Lab Clin Med; 1975 Sep 20; 86(3):395-409. PubMed ID: 168278
    [Abstract] [Full Text] [Related]

  • 8. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
    Melani F, Lawecki J, Bartelt KM, Pfeiffer EF.
    Diabetologia; 1967 Oct 20; 3(5):422-6. PubMed ID: 5620801
    [No Abstract] [Full Text] [Related]

  • 9. [Plasma insulin levels in endocrine diseases. I. Plasma insulin levels in normal subjects and diabetic patients].
    Ikeda M.
    Nihon Naibunpi Gakkai Zasshi; 1971 Aug 20; 47(5):282-90. PubMed ID: 5106320
    [No Abstract] [Full Text] [Related]

  • 10. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
    Bohannon NV, Lorenzi M, Grodsky GM, Karam JH.
    J Clin Endocrinol Metab; 1982 Feb 20; 54(2):459-62. PubMed ID: 7054228
    [Abstract] [Full Text] [Related]

  • 11. [The behaviour of the serum insulin level in non obese adult diabetics after intravenous glucose, tolbutamide and glucagon].
    Lawecki J, Rogala H, Czyzyk A, Kowalski H.
    Acta Diabetol Lat; 1970 Feb 20; 7(3):407-20. PubMed ID: 5515384
    [No Abstract] [Full Text] [Related]

  • 12. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S, Avruskin T, Reddy CM, Hashemi SE.
    Am J Med Sci; 1976 Feb 20; 271(1):35-9. PubMed ID: 943938
    [Abstract] [Full Text] [Related]

  • 13. Effects of tolbutamide and insulin on insulin inhibitory activity associated with plasma albumin.
    Devrim S, Kilo C, Voyles N, Recant L.
    Diabetes; 1968 Dec 20; 17(12):746-51. PubMed ID: 5726254
    [No Abstract] [Full Text] [Related]

  • 14. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range.
    Kosaka K, Hagura R, Kuzuya T, Kuzuya N.
    Diabetologia; 1974 Dec 20; 10(6):775-82. PubMed ID: 4442669
    [No Abstract] [Full Text] [Related]

  • 15. Acute insulin response to glucagon, tolbutamide, and glucose in non-insulin-dependent diabetes of the young.
    Naidoo C, Jialal I, Suleman A, Rajput MC, Joubert SM.
    Diabetes Care; 1986 Dec 20; 9(1):57-60. PubMed ID: 3512209
    [Abstract] [Full Text] [Related]

  • 16. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
    Bigelow-Sherman JD, Shima K, Borden EK, Foà PP, Penhallegon R.
    Acta Diabetol Lat; 1970 Dec 20; 7(1):68-92. PubMed ID: 5493440
    [No Abstract] [Full Text] [Related]

  • 17. Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation.
    Pozza G, Traeger J, Dubernard JM, Secchi A, Pontiroli AE, Bosi E, Malik MC, Ruitton A, Blanc N.
    Diabetologia; 1983 Apr 20; 24(4):244-8. PubMed ID: 6134651
    [Abstract] [Full Text] [Related]

  • 18. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
    Berchtold P, Büber V, Meier V, Felber JP, Keiser G.
    Diabetologia; 1971 Apr 20; 7(2):77-81. PubMed ID: 5581543
    [No Abstract] [Full Text] [Related]

  • 19. Insulin and glucagon secretion in BB wistar rats with impaired glucose tolerance.
    Nakhooda AF, Poussier P, Marliss EB.
    Diabetologia; 1983 Jan 20; 24(1):58-62. PubMed ID: 6337908
    [Abstract] [Full Text] [Related]

  • 20. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
    Vague P, Ramahandridona G, Vialettes B, Raymond JP, Vague J.
    Diabete Metab; 1978 Dec 20; 4(4):261-5. PubMed ID: 729892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.